Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
The TRANSCEND-T2D Phase 3 clinical trial program is evaluating the safety and efficacy of retatrutide for the treatment of adults with type 2 diabetes across three global registrational trials
What is the refund policy if I want to discontinue mid-bundle
[10] [11] Treatment starts with a lower dose (0.25 mg weekly), gradually increasing every 4 weeks (0.5 mg, 1.0 mg, 1.7 mg) until reaching the maintenance dose of 2.4 mg to minimise gastrointestinal side effects
It's important for applicants to meet eligibility requirements, such as age and residency, to ensure a smooth application process
Blockbuster drug: What it is, how it works
US$ 22.33
US$ 20.96
US$ 25.04
US$ 22.98
US$ 23.87
US$ 29.63
US$ 23.44
US$ 26.24
